Spiriva vs. Xopenex

See how Spiriva and Xopenex compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Spiriva is a once-daily long-term controller for COPD and asthma, while Xopenex is a fast-acting bronchodilator taken multiple times a day for quick symptom relief.

  • Spiriva does not relieve sudden breathing problems and is not a rescue inhaler, whereas Xopenex is designed to open airways quickly during an asthma or COPD flare.

  • Both drugs treat bronchospasm from obstructive airway disease, but they work through different mechanisms and are typically used together rather than as substitutes.

Spiriva vs. Xopenex Drug Summary

Spiriva

Spiriva (tiotropium) is a long-acting anticholinergic bronchodilator used for long-term maintenance of COPD and, with the Respimat device, asthma in patients 6 and older. It is inhaled once daily and is not meant to relieve sudden breathing symptoms.

Xopenex

Xopenex (levalbuterol) is a short-acting beta2-agonist bronchodilator used to treat or prevent bronchospasm in asthma, COPD, and other reversible airway conditions. It is delivered by nebulizer solution or HFA inhaler, typically several times a day as needed.

Spiriva vs. Xopenex Side Effects

Spiriva

Most common
pharyngitis (12.5%)
sinusitis (6.5%)
headache (5.7%)
constipation (5.1%)

Xopenex

Most common
pharyngitis (up to 2%)
bronchitis (up to 2%)
dizziness (up to 2%)
pain (up to 2%)

Spiriva vs. Xopenex Dosage

Spiriva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2.5 mcg once daily At the start
Maximum dose 18 mcg once daily If needed
Dose changes 2 increases As tolerated

Xopenex

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.31 mg three times daily At the start
Maximum dose 90 mcg (2 puffs) q4-6h If needed
Dose changes 4 increases As tolerated

Spiriva vs. Xopenex Indications

Spiriva

Spiriva is FDA-approved for long-term maintenance treatment of COPD, including chronic bronchitis and emphysema, and for reducing COPD exacerbations. The Respimat device is also approved for asthma maintenance in patients 6 and older. It is not for relief of sudden bronchospasm.

  • Long-term COPD maintenance treatment

  • Reduces COPD exacerbations

  • Asthma maintenance, ages 6+ (Respimat only)

  • Not for acute bronchospasm relief

Xopenex

Xopenex is FDA-approved to treat or prevent bronchospasm in patients with reversible obstructive airway disease such as asthma or COPD. It works quickly to relax airway muscles during a flare-up of breathing symptoms. It is not approved for managing preterm labor.

  • Treats acute bronchospasm episodes

  • Prevents trigger-induced bronchospasm

  • Used in asthma and COPD flare-ups

  • Not approved for preterm labor

Spiriva vs. Xopenex Pros and Cons

Spiriva

Spiriva is a once-daily long-acting bronchodilator that helps control COPD and asthma symptoms over time, but it does not relieve sudden breathing difficulty and requires a separate rescue inhaler. It carries anticholinergic risks like worsened glaucoma or urinary retention that patients with those conditions should discuss with their doctor.

Pros

  • Only needs to be taken once a day

  • Long-acting control that reduces COPD exacerbations

  • FDA-approved for both COPD and asthma (Respimat)

  • Two device options tailored to indication

Cons

  • Not for acute symptoms; needs a separate rescue inhaler

  • Roughly $600 to $630 per month without insurance, before savings programs

  • May worsen glaucoma or urinary retention

  • Slower onset, unsuitable for sudden breathing distress

Xopenex

Xopenex is a fast-acting bronchodilator used for quick relief or prevention of bronchospasm, delivered through a nebulizer or inhaler multiple times a day. It does not treat the underlying airway inflammation behind asthma or COPD, so it is often paired with a long-term controller like Spiriva.

Pros

  • Fast onset for quick relief of bronchospasm

  • Available in both nebulizer and inhaler forms

  • Roughly $55 to $120 per month without insurance, before savings programs

  • Single-isomer formula may cause fewer side effects than albuterol

Cons

  • Requires dosing multiple times a day, up to every 4 hours

  • Does not treat underlying airway inflammation

  • Risk of cardiovascular effects like rapid heartbeat

  • Excessive use can be dangerous or fatal

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.